trexan 25 mg/ml injektioneste, liuos, esitäytetty ruisku
orion corporation - methotrexate - injektioneste, liuos, esitäytetty ruisku - 25 mg/ml - metotreksaatti
trexan 2.5 mg tabletti
orion corporation - methotrexatum - tabletti - 2.5 mg - metotreksaatti
trexan 10 mg tabletti
orion corporation - methotrexatum - tabletti - 10 mg - metotreksaatti
methotrexat accord 25 mg/ml injektioneste, liuos
accord healthcare b.v. - methotrexate - injektioneste, liuos - 25 mg/ml - metotreksaatti
methotrexat accord 100 mg/ml infuusiokonsentraatti, liuosta varten
accord healthcare b.v. - methotrexate - infuusiokonsentraatti, liuosta varten - 100 mg/ml - metotreksaatti
methotrexate pfizer 100 mg/ml infuusiokonsentraatti, liuosta varten
pfizer oy pfizer oy - methotrexatum - infuusiokonsentraatti, liuosta varten - 100 mg/ml - metotreksaatti
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomidi - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomidi - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit, selektiiviset immunosuppressantit - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
trexan 2.5 mg tabletti
orion corporation - methotrexate disodium - tabletti - 2.5 mg - metotreksaatti
trexan 10 mg tabletti
orion corporation - methotrexate disodium - tabletti - 10 mg - metotreksaatti